- **Aditxt, Inc.** issued **senior unsecured notes** with an aggregate original principal amount of **$212,500** on **September 12, 2025**. These notes bear interest at a rate of **10% per annum** and have a maturity date of **September 30, 2025**.  **[1726711_0001213900-25-088210_ea0257612-8k_aditxt.htm:1]** 
- The company is required to use **100% of the gross proceeds** from sales of common stock through at-the-market offerings or equity-line transactions to repay these notes.  **[1726711_0001213900-25-088210_ea0257612-8k_aditxt.htm:1]** 
- The **2025 annual meeting of stockholders** was adjourned from **September 16, 2025**, to **September 23, 2025**, to allow additional time for stockholders to vote.  **[1726711_0001213900-25-088210_ea0257612-8k_aditxt.htm:4]** 
- Key proposals to be voted on at the adjourned meeting include the election of **five (5) members** to the board of directors, the ratification of **dbb _mckennon_** as the independent auditor, and granting discretionary authority for a **reverse stock split** at a ratio between **1-for-5 and 1-for-250**.  **[1726711_0001213900-25-088210_ea0257612-8k_aditxt.htm:4]**

Aditxt, Inc. Issues Senior Unsecured Notes and Adjourns Annual Meeting for Reverse Stock Split Vote

- Aditxt, Inc. and Evofem Biosciences, Inc. entered into the **sixth amendment** to their Amended and Restated Merger Agreement on **August 26, 2025**.  **[1726711_0001213900-25-081146_ea025472601ex10-1_aditxt.htm:0]** 
- This amendment updates the definition of "Unconverted Company Preferred Stock" to include **Evofem's Series G-1 Preferred Stock**.  **[1726711_0001213900-25-081146_ea0254726-8k_aditxt.htm:2]** 
- It also clarifies that Evofem will assist in obtaining Exchange Agreements for convertible noteholders to exchange their notes for **not more than 89,021 shares of Aditxt's preferred stock**.  **[1726711_0001213900-25-081146_ea025472601ex10-1_aditxt.htm:0]** **[1726711_0001213900-25-081146_ea0254726-8k_aditxt.htm:2]** 
- The amendment sets limits on dissenting shares, allowing for **no more than 5,932,818 common shares or 202 preferred shares**.  **[1726711_0001213900-25-081146_ea025472601ex10-1_aditxt.htm:1]** **[1726711_0001213900-25-081146_ea0254726-8k_aditxt.htm:2]** 
- A new **Series A-2 Convertible Preferred Stock** of Aditxt, Inc., with a stated value of **$1,000 per share**, is introduced as part of the merger consideration.  **[1726711_0001213900-25-081146_ea025472601ex10-1_aditxt.htm:2]**

Aditxt (ADTX)